CN114436836B - Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound - Google Patents

Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound Download PDF

Info

Publication number
CN114436836B
CN114436836B CN202210064220.5A CN202210064220A CN114436836B CN 114436836 B CN114436836 B CN 114436836B CN 202210064220 A CN202210064220 A CN 202210064220A CN 114436836 B CN114436836 B CN 114436836B
Authority
CN
China
Prior art keywords
methyl
methoxy
phenyl
ester compound
phenylpropionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210064220.5A
Other languages
Chinese (zh)
Other versions
CN114436836A (en
Inventor
马学骥
孙爱丽
李峰
王凯凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang University
Original Assignee
Xinxiang University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang University filed Critical Xinxiang University
Priority to CN202210064220.5A priority Critical patent/CN114436836B/en
Publication of CN114436836A publication Critical patent/CN114436836A/en
Application granted granted Critical
Publication of CN114436836B publication Critical patent/CN114436836B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C67/347Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

The invention discloses a method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound, which utilizes the catalytic action of cheap copper catalyst and P, N-chiral ligand to synthesize the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound in one step, and has the advantages of easily obtained raw materials, simple preparation method and good yield and enantioselectivity; meanwhile, the catalyst consumption is small, and the cost can be greatly reduced. The method can be used for synthesizing key intermediates of tolterodine for treating overactive bladder.

Description

Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compounds.
Background
2,3 diaryl substituted propionic acid esters are key intermediates of some important drugs, such as Tolterodine (Tolterodine), the dominant drug in the treatment of overactive bladder (OAB). OAB is of great interest and importance in the european and american countries, and the drug varieties for treatment of OAB mainly include solifenacin, tolterodine, fexodine and propiverine, which are sold in the amount of dollars 27.24 to about 25% of the total sales of all drugs for treatment of urinary system diseases, with tolterodine being dominant in the amount of dollars 16.90. The general synthetic scheme for tolterodine molecules and their enantiomers is shown in formula (1-1).
As shown in the formula (1-1), the tolterodine molecular structure contains 1 chiral center, the traditional synthetic route needs chiral resolution to obtain the optically pure tolterodine drug, and in industrialization, the theoretical yield of the chiral resolution synthetic drug is only 50%, and the actual production yield is far less than 50%. Therefore, the key intermediate is asymmetrically synthesized, and the realization of high yield and high stereoselectivity for controlling the synthesis of the medicine has very important scientific significance and practical value.
In recent years, rhodium catalyzed reports of asymmetric addition reactions of phenylboronic acid to alpha, beta-unsaturated ketone compounds can be used for synthesizing tolterodine key intermediate-2, 3 diaryl substituted ketone and propionate. However, expensive rhodium catalysts limit the application of this process. While inexpensive copper-catalyzed synthesis of 2,3 diaryl substituted propionic acid esters lacks relevant reports.
Disclosure of Invention
Aiming at the prior art, the invention provides a method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound to solve the problems of expensive catalyst and difficult chiral resolution.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows: a process for the preparation of methyl (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionate is provided. The preparation method comprises the following steps:
3- (2-methoxy-5-methyl) phenyl methyl acrylate and phenylboronic acid compound are dissolved in an organic solvent, and then a catalyst and a P, N-chiral ligand are added, and the mixture is uniformly mixed and reacted for 1 to 4 hours at the temperature of 40 to 100 ℃ to obtain the catalyst;
the structural formula of the phenylboronic acid compound is shown as a formula (I),
the structural formula of the P, N-type chiral ligand is shown as a formula (II),
wherein R is a chlorine atom, a fluorine atom, a cyano group, or a trifluoromethyl groupA group, an oxytrifluoromethyl group, an aryl group, a heteroaryl group or a saturated alkyl group having 1 to 12 carbon atoms; r is R 1 Is a saturated alkyl group, a substituted phenyl group, a chlorine atom, a fluorine atom or a heteroaryl group; r is R 2 Is phenyl or substituted phenyl; the structural formula of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound is shown as a formula (III),
the reaction equation for preparing the compounds of the present invention is as follows:
on the basis of the technical scheme, the invention can be improved as follows.
Further, the organic solvent is tetrahydrofuran, chlorobenzene, toluene, xylene, mesitylene or ethyl acetate.
Further, the molar ratio of the 3- (2-methoxy-5-methyl) phenyl methyl acrylate to the phenylboronic acid compound is 1:1-1:3; the molar ratio of the catalyst to the 3- (2-methoxy-5-methyl) phenyl methyl acrylate is 0.005-0.1:1.
Further, the catalyst is a copper catalyst.
Further, the catalyst is cuprous chloride, cuprous bromide, cupric acetate or copper trifluoromethane sulfonate.
Further, aryl is phenyl or naphthyl; heteroaryl is furyl or thienyl.
The beneficial effects of the invention are as follows:
the method synthesizes the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenyl methyl propionate compound in the next step by using the catalysis of the cheap copper catalyst and the P, N-type chiral ligand, has the advantages of easily obtained raw materials, simple preparation method and good yield and enantioselectivity. Meanwhile, the catalyst consumption is small, and the cost can be greatly reduced. The method can be used for synthesizing a series of 2,3 diaryl substituted propionate compounds, and the synthesized product has biological activity.
Detailed Description
The following describes the present invention in detail with reference to examples.
Example 1
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 78mg of phenylboronic acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, the mixture is cooled to room temperature and directly passes through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1), 108mg of a product is obtained, the yield is 76%, ee 89%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.40(t,J=7.6Hz,2H),7.29(d,J=7.6Hz,2H),7.27(d,J=7.6Hz,1H),7.05(s,1H),6.94(d,J=7.2Hz,1H),6.82(d,J=7.2Hz,1H),4.69(dd,J=3.2,1.2Hz,1H),3.83(s,3H),3.68(s,3H),3.00(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.34(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=174.3,161.8,142.7,131.4,128.9,127.7,127.3,112.4,57.9,53.0,44.8,38.1,21.6.
HRMS: molecular formula C 18 H 21 O 3 Calculated as 285.1491 and detected as 285.1489.
Example 2
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
to a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 97mg of phenylboronic acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, the mixture is cooled to room temperature and directly passes through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1), 114mg of a product is obtained, the yield is 73%, ee 91%, and the reaction process is shown in the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.38(t,J=7.6Hz,2H),7.31(d,J=7.6Hz,2H),7.23(d,J=7.6Hz,1H),7.10(s,1H),6.77(d,J=7.2Hz,1H),4.59(dd,J=3.2,1.2Hz,1H),3.81(s,3H),3.66(s,3H),3.07(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.62(q,J=7.6Hz,2H),2.34(s,3H),1.25(t,J=7.6Hz,3H).
13 C NMR(400MHz,CDCl 3 ):δ=175.1,161.7,141.9,132.2,128.5,127.3,127.1,112.1,58.2,53.1,44.5,38.2,28.2,21.6,14.5.
HRMS: molecular formula C 20 H 25 O 3 Calculated as 313.1804 and detected as 313.1806.
Example 3
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
to a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 93mg of 4-fluorophenylboric acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, cooling to room temperature, and directly passing through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1) to obtain 106mg of a product, wherein the yield is 70%, ee 89%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.43(t,J=7.6Hz,2H),7.37(d,J=7.6Hz,2H),7.27(d,J=7.6Hz,1H),7.14(s,1H),6.82(d,J=7.2Hz,1H),4.63(dd,J=3.2,1.2Hz,1H),3.85(s,3H),3.70(s,3H),3.09(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.38(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=176.1,162.4,141.7,131.9,128.9,127.4,127.2,113.0,58.6,53.8,44.7,38.1,21.6.
HRMS: molecular formula C 18 H 20 FO 3 Calculated as 303.1396 and detected as 303.1395.
Example 4
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 97mg of 4-cyanobenzeneboronic acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 38mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred at 60℃for 2 hours under nitrogen. After the reaction is finished, cooling to room temperature, and directly passing through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 10:1) to obtain 110mg of a product, wherein the yield is 71%, ee 90%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.45(t,J=7.6Hz,2H),7.35(d,J=7.6Hz,2H),7.29(d,J=7.6Hz,1H),6.82(d,J=7.2Hz,1H),7.15(s,1H),4.63(dd,J=3.2,1.2Hz,1H),3.87(s,3H),3.71(s,3H),3.10(dd,J=3.2,1.2Hz,1H),2.70(dd,J=3.2,1.2Hz,1H),2.38(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=176.3,162.3,156.4,141.4,131.8,127.9,127.1,126.2,114.1,58.8,53.8,44.9,38.2,21.6.
HRMS: molecular formula C 19 H 20 NO 3 Calculated as 310.1443 and detected as 310.1446.
Example 5
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
to a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 117mg of 4-phenylphenylboric acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred at 60℃for 3 hours under nitrogen. After the reaction is finished, the mixture is cooled to room temperature and directly passes through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 10:1), 132mg of a product is obtained, the yield is 68%, ee 86%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.52(d,J=7.6Hz,2H),7.50(t,J=7.6Hz,2H),7.41(d,J=7.6Hz,1H),7.40(d,J=7.6Hz,2H),7.35(d,J=7.6Hz,2H),7.05(s,1H),6.94(d,J=7.2Hz,1H),6.82(d,J=7.2Hz,1H),4.69(dd,J=3.2,1.2Hz,1H),3.84(s,3H),3.70(s,3H),3.05(dd,J=3.2,1.2Hz,1H),2.77(dd,J=3.2,1.2Hz,1H),2.35(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=173.3,160.6,141.9,140.8,138.3,131.4,131.2,131.1,129.2,128.7,128.4,127.9,127.6,127.5,112.2,56.1,51.9,38.6,21.6.
HRMS: molecular formula C 24 H 25 O 3 Calculated as 361.1804 and detected as 361.1803.
Example 6
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 97mg of 4-cyanobenzeneboronic acid, 2.0mg of cuprous chloride, 7.8mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, cooling to room temperature, and directly passing through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 10:1) to obtain 110mg of a product, wherein the yield is 71%, ee 90%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.86(d,J=7.6Hz,1H),7.74(d,J=8.0Hz,2H),7.35(d,J=8.0Hz,2H),7.07(d,J=7.6Hz,1H),7.05(s,1H),6.94(d,J=7.6Hz,1H),6.82(d,J=7.6Hz,1H),6.68(dd,J=7.6Hz,1H),4.69(dd,J=3.2,1.2Hz,1H),3.83(s,3H),3.68(s,3H),3.02(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.34(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=173.1,160.6,154.0,143.0,142.9,131.8,131.2,131.1,128.7,127.8,127.5,125.5,112.2,122.0,112.1,56.8,51.8,38.9,21.6.
HRMS: molecular formula C 22 H 23 O 4 Calculated as 351.1596 and detected as 351.1596.
Example 7
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 78mg of phenylboronic acid, 2.0mg of cuprous chloride, 8.9mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, cooling to room temperature, and directly passing through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1) to obtain 114mg of a product, wherein the yield is 73%, ee 88%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.40(t,J=7.6Hz,2H),7.29(d,J=7.6Hz,2H),7.27(d,J=7.6Hz,1H),6.94(d,J=7.2Hz,1H),6.82(d,J=7.2Hz,1H),7.05(s,1H),4.69(dd,J=3.2,1.2Hz,1H),3.83(s,3H),3.68(s,3H),3.00(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.34(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=174.3,161.8,142.7,131.4,128.9,127.7,127.3,112.4,57.9,53.0,44.8,38.1,21.6.
HRMS: molecular formula C 18 H 21 O 3 Calculated as 285.1491 and detected as 285.1489.
Example 8
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 78mg of phenylboronic acid, 2.0mg of cuprous chloride, 10.4mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, the mixture is cooled to room temperature and directly passes through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1), 117mg of a product is obtained, the yield is 75%, ee 86%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.40(t,J=7.6Hz,2H),7.29(d,J=7.6Hz,2H),7.27(d,J=7.6Hz,1H),6.94(d,J=7.2Hz,1H),6.82(d,J=7.2Hz,1H),7.05(s,1H),4.69(dd,J=3.2,1.2Hz,1H),3.83(s,3H),3.68(s,3H),3.00(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.34(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=174.3,161.8,142.7,131.4,128.9,127.7,127.3,112.4,57.9,53.0,44.8,38.1,21.6.
HRMS: molecular formula C 18 H 21 O 3 Calculated as 285.1491 and detected as 285.1489.
Example 9
The preparation method of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound specifically comprises the following steps:
in a dry 15mL pressure-resistant reaction tube, 103mg of methyl 3- (2-methoxy-5-methyl) phenylacrylate (CAS: 86761-35-5), 78mg of phenylboronic acid, 2.0mg of cuprous chloride, 8.3mg of P, N-type chiral ligand, 138mg of potassium carbonate and 2.5mL of tetrahydrofuran were added. The reaction was stirred for 2 hours at 50℃under nitrogen. After the reaction is finished, cooling to room temperature, and directly passing through a silica gel column (the volume ratio of petroleum ether to ethyl acetate is 15:1) to obtain 109mg of a product, wherein the yield is 70%, ee 87%, and the reaction process is shown as the following formula:
nuclear magnetic resonance and mass spectrometry were performed on the product prepared in this example:
1 H NMR(400MHz,CDCl 3 ):δ=7.40(t,J=7.6Hz,2H),7.29(d,J=7.6Hz,2H),7.27(d,J=7.6Hz,1H),6.94(d,J=7.2Hz,1H),6.82(d,J=7.2Hz,1H),7.05(s,1H),4.69(dd,J=3.2,1.2Hz,1H),3.83(s,3H),3.68(s,3H),3.00(dd,J=3.2,1.2Hz,1H),2.75(dd,J=3.2,1.2Hz,1H),2.34(s,3H).
13 C NMR(400MHz,CDCl 3 ):δ=174.3,161.8,142.7,131.4,128.9,127.7,127.3,112.4,57.9,53.0,44.8,38.1,21.6.
HRMS: molecular formula C 18 H 21 O 3 Calculated as 285.1491 and detected as 285.1489.
While specific embodiments of the invention have been described in detail in connection with the examples, it should not be construed as limiting the scope of protection of the patent. Various modifications and variations which may be made by those skilled in the art without the creative effort are within the scope of the patent described in the claims.

Claims (3)

1. A process for the preparation of (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound comprising the steps of:
3- (2-methoxy-5-methyl) phenyl methyl acrylate and phenylboronic acid compound are dissolved in an organic solvent, cuprous chloride, P, N-chiral ligand and potassium carbonate are added, and the mixture is uniformly mixed and then reacted for 1 to 4 hours at the temperature of 40 to 100 ℃ to obtain the catalyst;
the structural formula of the phenylboronic acid compound is shown as a formula (I),
the P, N-type chiral ligand is selected from,
wherein R is fluorine atom, cyano or phenyl;
the structural formula of the (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound is shown as a formula (III),
2. the method of manufacturing according to claim 1, characterized in that: the organic solvent is tetrahydrofuran, chlorobenzene, toluene, xylene, mesitylene or ethyl acetate.
3. The method of manufacturing according to claim 1, characterized in that: the molar ratio of the 3- (2-methoxy-5-methyl) phenyl methyl acrylate to the phenylboronic acid compound is 1:1-1:3; the molar ratio of the cuprous chloride to the 3- (2-methoxy-5-methyl) phenyl methyl acrylate is 0.005-0.1:1.
CN202210064220.5A 2022-01-20 2022-01-20 Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound Active CN114436836B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210064220.5A CN114436836B (en) 2022-01-20 2022-01-20 Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210064220.5A CN114436836B (en) 2022-01-20 2022-01-20 Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound

Publications (2)

Publication Number Publication Date
CN114436836A CN114436836A (en) 2022-05-06
CN114436836B true CN114436836B (en) 2023-09-29

Family

ID=81367301

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210064220.5A Active CN114436836B (en) 2022-01-20 2022-01-20 Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound

Country Status (1)

Country Link
CN (1) CN114436836B (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Bin Li,et al.Cu-Catalyzed Enantioselective Ring Opening of Cyclic Diaryliodoniums toward the Synthesis of Chiral Diarylmethanes.《J. Am. Chem. Soc.》.2018,第140卷第9400−9403页. *
Gaurav Dahiya, et al.Configuration Sampling With Five-Membered Atropisomeric P,NLigands.《Angew. Chem. Int. Ed.》.2021,第60卷第19604-19608页. *

Also Published As

Publication number Publication date
CN114436836A (en) 2022-05-06

Similar Documents

Publication Publication Date Title
CN111574450B (en) Novel chiral biphenyl quaternary ammonium salt phase transfer catalyst and preparation method and application thereof
CN113788756B (en) Method for synthesizing optically pure allyl alcohol compound through diacid catalysis in green mode
CN114437103A (en) Method for synthesizing chiral tetrahydrobenzoxepin compound through gold-catalyzed asymmetric cycloaddition reaction
CN112940002B (en) Method for synthesizing octatomic bridged ring compound through palladium-catalyzed asymmetric ring addition reaction
CN113735756B (en) Method for synthesizing chiral 3, 3-disubstituted isoindolinone compound by rhodium catalysis
CN114436836B (en) Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound
CN113549062A (en) Chiral quaternary ammonium salt phase transfer catalyst with high steric hindrance derived from cinchona alkaloid and synthesis method thereof
EP1724251A1 (en) Process for production of optically active hydroxymethylated compounds
CN109535120B (en) Preparation method of 7-substituted-3, 4,4, 7-tetrahydrocyclobutane coumarin-5-ketone
CN112694430B (en) Preparation method of 1, 5-dihydro-2H-pyrrole-2-ketone compound
CN112939780B (en) Synthetic method of indanone derivatives
CN111499538B (en) Preparation method of (2S, 3R) -2-acylaminomethyl-3-hydroxybutyrate
JP3716460B2 (en) Asymmetric cyclopropanation reaction
CN111100085A (en) Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound
CN107176959B (en) A kind of chiral spiro hydroxyindole dihydropyran derivatives and its synthetic method
Zhu et al. Template effect of Pd (II) in the synthesis of differently substituted enantiopure γ-butyrolactones and its synthetic applications
EP0592881A2 (en) Process for producing optically active gamma-hydroxyketones
CN115353457B (en) Asymmetric carbonate and preparation method thereof
CN115745822B (en) Preparation method of N-formylamide compound catalyzed by visible light
CN113234083B (en) Tetrahydroquinoline pyran compound and preparation method and application thereof
CN111410656B (en) Preparation method of isoquinolone derivative
CN110183362B (en) Process for producing aromatic alkenyl compound
CN113387883A (en) Catalytic synthesis method of 8-substituted quinoline compound
CN117447356A (en) Cyclopentenone derivative and synthesis method and application thereof
CN115108965A (en) Preparation method of anti-neocoronarism drug Parovidekey intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant